Skip to main content
Lack of resistant SMO mutations and decreased mutational load of Gorlin-associated basal cell cancers explain marked response to smoothened inhibitors Sarin, K., Rezaee, M., Jaju, P., Chang, A. S., Oro, A., Epstein, E., Tang, J. Y. NATURE PUBLISHING GROUP. 2015: S23

View details for Web of Science ID 000352783200136